The Kidney Allocation System

Surgical Clinics of North America

Volumn 93, Issue 6, 2013, Pages 1395-1406

  Friedewald, John J ^a   Samana, Ciara J ^b   Kasiske, Bertram L ^c,d   Israni, Ajay K ^c,d,e   Stewart, Darren ^b   Cherikh, Wida ^b   Formica, Richard N ^f  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNITED NETWORK FOR ORGAN SHARING   (United States)

^c MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^d HENNEPIN COUNTY MEDICAL CENTER   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Kidney transplant; Organ allocation; Transplant waiting list

Indexed keywords

HLA ANTIGEN;

AGE; CONSULTATION; CREATININE CLEARANCE; DIALYSIS; DYING; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEALTH CARE POLICY; HISTOCOMPATIBILITY; HOSPITAL ADMISSION; HUMAN; IMMUNE SYSTEM; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LIFE EXPECTANCY; LIVING DONOR; LONGEVITY; PRIORITY JOURNAL; RESOURCE ALLOCATION; REVIEW; RISK ASSESSMENT; SENSITIZATION; SURVIVAL;

KIDNEY TRANSPLANT; ORGAN ALLOCATION; TRANSPLANT WAITING LIST;

DONOR SELECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; LIFE EXPECTANCY; RISK ASSESSMENT; TISSUE AND ORGAN PROCUREMENT; WAITING LISTS;

EID: 84887254569     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2013.08.007     Document Type: Review

References (8)

1. Wolfe R.A., Ashby V.B., Milford E.L., et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. NEngl J Med 1999, 341:1725-1730.
2. Stratta P., Coppo R. Audit on quality of life of patients with chronic kidney disease on dialysis and after transplant. GItal Nefrol 2008, 25(Suppl 41):S45-S57. [inItalian].
3. Park I.H., Yoo H.J., Han D.J., et al. Changes in the quality of life before and after renal transplantation and comparison of the quality of life between kidney transplant recipients, dialysis patients, and normal controls. Transplant Proc 1996, 28:1937-1938.
4. United States Congress House Committee on Ways and Means.Subcommittee on Health National Organ Transplant Act: hearing before the Subcommittee onHealth of the Committee on Ways and Means, House of Representatives, Ninety-eighth Congress, second session, on H.R. 4080. February 9, 1984 1984, U.S. G.P.O., Washington, DC.
5. McCormick T.R. Principles of bioethics 1998, University of Washington School of Medicine, Modified 2008. Available at:, Accessed April 29, 2013. http://depts.washington.edu/bioethx/tools/princpl.html.
6. Health Resources and Services Administration/Organ Procurement and Transplantation Network Kidney Transplantation Committee. Concepts for kidney allocation. 2011. Available at:. Accessed April 29, 2013. http://optn.transplant.hrsa.gov/SharedContentDocuments/KidneyConceptDocument.PDF.
7. Roa P.S., Schaubel D.E., Guidinger M.K., et al. Acomprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplantation 2009, 88:231-236.
8. Israni A, Gustafson S, Salkowski N, etal. New proposed national allocation policy for deceased donor kidneys in the US and its possible impact on patient outcomes [abstract]. Am J Transplant, in press. Available at:. http://www.atcmeetingabstracts.com/.